A High-Octane YOLO Play on Lyra Therapeutics.Lyra Therapeutics, Inc., a nascent player in the biopharmaceutical sector, exhibits stark volatility and considerable downside movement in its recent stock performance. As it hovers at a near all-time low of $0.4455, this report presents a speculative analysis based on a blend of technical indicator